Pancreas transplantation: A treatment option for people with diabetes

Diabetic Medicine

Volumn 31, Issue 5, 2014, Pages 512-521

  Mittal, S ^a,b,c   Gough, S C L ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Oxford Centre for Diabetes Endocrinology and Metabolism   (United Kingdom)

^c NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TACROLIMUS;

ALGORITHM; ARTICLE; BLOOD GLUCOSE MONITORING; CEREBROVASCULAR ACCIDENT; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; END STAGE RENAL DISEASE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GRAFT SURVIVAL; HEART FUNCTION; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPPORTUNISTIC INFECTION; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PANCREAS TRANSPLANTATION; PERIPHERAL VASCULAR DISEASE; QUALITY OF LIFE; RISK FACTOR; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DONOR; TRANSPLANTATION;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84898603830     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12373     Document Type: Article

References (86)

1. Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 1967; 61: 827-837.
2. Lillehei RC, Simmons RL, Najarian JS, Goetz FC. Pancreatico-duodenal and renal allotransplantation in juvenile onset, insulin dependent, diabetes mellitus with terminal nephropathy. Langenbecks Archiv fur Chirurgie 1970; 326: 88-105.
3. National Data Reports. Organ Procurement and Transplantation Network. July 2013. Available at http://optn.transplant.hrsa.gov/latestData/rptStrat.asp. Last accessed 3 July 2013.
4. Trial. C. American Diabetes Association. Pancreas Transplantaion for Patient with Type 1 Diabetes. Diabetes Care 2002; 25: S111.
5. Gruessner AC, Gruessner RW. Pancreas transplant outcomes for United States and non United States cases as reported to the United Network for Organ Sharing and the International Pancreas Transplant Registry as of December 2011. Clin Transpl 2012; 23-40.
6. Activity Report 2012. NHS Blood and Transplant. Available at http://www.organdonation.nhs.uk/statistics/transplant_activity_report. Last accessed 3 July 2013.
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New Eng J Med 1993; 329: 977-986.
8. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013; 36: 1384-1395.
9. Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 347: f4533.
10. Gruessner RW, Gruessner AC. The current state of pancreas transplantation. Nat Rev Endocrinol 2013; 9: 555-562.
11. Kandaswamy R, Stock PG, Skeans MA, Gustafson SK, Sleeman EF, Wainright JL et al. OPTN/SRTR 2011 Annual Data Report: pancreas. Am J Transplant 2013; 13: 47-72.
12. Smail N, Paraskevas S, Tan X, Metrakos P, Cantarovich M. Renal function in recipients of pancreas transplant alone. Curr Opin Organ Transplant 2012; 17: 73-79.
13. Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus. http://publications.nice.org.uk/allogeneic-pancreatic-islet-cell-transplantation-for-type-1-diabetes-mellitus-ipg257. Last accessed 23 October 2013.
14. Muthusamy AS, Mumford L, Hudson A, Fuggle SV, Friend PJ. Pancreas transplantation from donors after circulatory death from the United Kingdom. Am J Transplant 2012; 12: 2150-2156.
15. Ziaja J, Krol R, Pawlicki J, Heitzman M, Wilk J, Kowalik A et al. Donor-dependent risk factors for early surgical complications after simultaneous pancreas-kidney transplantation. Transplant Proc 2011; 43: 3092-3096.
16. Proneth A, Schnitzbauer AA, Zeman F, Foerster JR, Holub I, Arbogast H et al. Extended pancreas donor program - the EXPAND study rationale and study protocol. Transplant Res 2013; 2: 12.
17. Axelrod DA, Sung RS, Meyer KH, Wolfe RA, Kaufman DB. Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization. Am J Transplant 2010; 10: 837-845.
18. NHSBT Organ Donation and Transplantation Patient Selection and Allocation Policies, Pancreas: Allocation. Available at http://www.odt.nhs.uk/pdf/pancreas_allocation_policy.pdf. Last accessed 29 August 2013.
19. Han DJ, Sutherland DE. Pancreas transplantation. Gut Liver 2010; 4: 450-465.
20. Bazerbachi F, Selzner M, Marquez MA, Norgate A, Aslani N, McGilvray ID et al. Portal venous versus systemic venous drainage of pancreas grafts: impact on long-term results. Am J Transplant 2012; 12: 226-232.
21. Stadler M, Anderwald C, Pacini G, Zbyn S, Promintzer-Schifferl M, Mandl M et al. Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver. Diabetes 2010; 59: 215-218.
22. Sollinger HW, Odorico JS, Becker YT, D'Alessandro AM, Pirsch JD. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 2009; 250: 618-630.
23. Van der Werf WJ, Odorico JS, D'Alessandro AM, Knechtle SJ, Pirsch JD, Kalayoglu M et al. Enteric conversion of bladder-drained pancreas allografts: experience in 95 patients. Transplant Proc 1998; 30: 441-442.
24. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl 2008: 45-56.
25. Kandula P, Fridell J, Taber TE, Sharfuddin A, Yaqub MS, Phillips CL et al. Impact of tacrolimus-sirolimus maintenance immunosuppression on proteinuria and kidney function in pancreas transplant alone recipients. Transplantation 2012; 94: 940-946.
26. Diem P, Redmon JB, Abid M, Moran A, Sutherland DE, Halter JB et al. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 1990; 86: 2008-2013.
27. Choudhary P, Amiel SA. Hypoglycaemia: current management and controversies. Postgrad Med J 2011; 87: 298-306.
28. Dieterle CD, Veitenhansl M, Gutt B, Arbogast H, Meier GR, Illner WD et al. Impaired glucose tolerance in pancreas grafted diabetic patients is due to insulin secretory defects. Exp Clin Endocrinol Diabetes 2007; 115: 647-653.
29. Pfeffer F, Nauck MA, Benz S, Gwodzinski A, Zink R, Busing M et al. Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients. Diabetologia 1996; 39: 462-468.
30. Christiansen E, Tibell A, Volund AA, Holst JJ, Rasmussen K, Schaffer L et al. Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance. J Clin Endocrinol Metab 1997; 82: 2299-2307.
31. Pfeffer F, Nauck MA, Drognitz O, Benz S, von Dobschuetz E, Hopt UT. Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas-kidney transplantation. Transplantation 2003; 76: 1427-1431.
32. Battezzati A, Benedini S, Caldara R, Calori G, Secchi A, Pozza G et al. Prediction of the long-term metabolic success of the pancreatic graft function. Transplantation 2001; 71: 1560-1565.
33. Neidlinger N, Singh N, Klein C, Odorico J, Munoz del Rio A, Becker Y et al. Incidence of and risk factors for posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant 2010; 10: 398-406.
34. Troppmann C, Gruessner AC, Papalois BE, Sutherland DE, Matas AJ, Benedetti E et al. Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome. Transplantation 1996; 61: 1323-1330.
35. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant 2008; 8: 175-182.
36. van Dellen D, Worthington J, Mitu-Pretorian OM, Ghazanfar A, Forgacs B, Pararajasingam R et al. Mortality in diabetes: pancreas transplantation is associated with significant survival benefit. Nephrol Dial Transplant 2013; 28: 1315-1322.
37. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman A, Magee JC, Cibrik D et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71: 82-90.
38. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270: 1339-1343.
39. Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A, Groth CG. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999; 67: 645-648.
40. Mohan P, Safi K, Little DM, Donohoe J, Conlon P, Walshe JJ et al. Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg 2003; 90: 1137-1141.
41. Smets YF, Westendorp RG, van der Pijl JW, de Charro FT, Ringers J, de Fijter JW et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999; 353: 1915-1919.
42. Rayhill SC, D'Alessandro AM, Odorico JS, Knechtle SJ, Pirsch JD, Heisey DM et al. Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg 2000; 231: 417-423.
43. Reddy KS, Stablein D, Taranto S, Stratta RJ, Johnston TD, Waid TH et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 2003; 41: 464-470.
44. Morath C, Zeier M, Dohler B, Schmidt J, Nawroth PP, Opelz G. Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol 2008; 19: 1557-1563.
45. Weiss AS, Smits G, Wiseman AC. Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation. Clin J Am Soc Nephrol 2009; 4: 988-995.
46. Salvalaggio PR, Dzebisashvili N, Pinsky B, Schnitzler MA, Burroughs TE, Graff R et al. Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients. Diabetes Care 2009; 32: 600-602.
47. Norman SP, Kommareddi M, Ojo AO, Luan FL. Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantation. Transplantation 2011; 92: 796-801.
48. Ziaja J, Bozek-Pajak D, Kowalik A, Krol R, Cierpka L. Impact of pancreas transplantation on the quality of life of diabetic renal transplant recipients. Transplant Proc 2009; 41: 3156-3158.
49. Speight J, Reaney MD, Woodcock AJ, Smith RM, Shaw JA. Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic review. Diabetic Med 2010; 27: 812-822.
50. Gross CR, Limwattananon C, Matthees BJ. Quality of life after pancreas transplantation: a review. Clin Transplant 1998; 12: 351-361.
51. Goetzmann L, Ruegg L, Stamm M, Ambuhl P, Boehler A, Halter J et al. Psychosocial profiles after transplantation: a 24-month follow-up of heart, lung, liver, kidney and allogeneic bone-marrow patients. Transplantation 2008; 86: 662-668.
52. Dew MA, Switzer GE, DiMartini AF, Matukaitis J, Fitzgerald MG, Kormos RL. Psychosocial assessments and outcomes in organ transplantation. Prog Transplant 2000; 10: 239-259.
53. Hathaway DK, Hartwig MS, Milstead J, Elmer D, Evans S, Gaber AO. Improvement in quality of life reported by diabetic recipients of kidney-only and pancreas-kidney allografts. Transplant Proc 1994; 26: 512-514.
54. Gross CR, Zehrer CL. Health-related quality of life outcomes of pancreas transplant recipients. Clin Transplant 1992; 6: 165-171.
55. Margreiter C, Pratschke J, Margreiter R. Immunological monitoring after pancreas transplantation. Curr Opinion Organ Transplant 2013; 18: 71-75.
56. Low G, Crockett AM, Leung K, Walji AH, Patel VH, Shapiro AM et al. Imaging of vascular complications and their consequences following transplantation in the abdomen. Radiographics 2013; 33: 633-652.
57. Prieto M, Sutherland DE, Fernandez-Cruz L, Heil J, Najarian JS. Experimental and clinical experience with urine amylase monitoring for early diagnosis of rejection in pancreas transplantation. Transplantation 1987; 43: 73-79.
58. Klassen DK, Weir MR, Cangro CB, Bartlett ST, Papadimitriou JC, Drachenberg CB. Pancreas allograft biopsy: safety of percutaneous biopsy-results of a large experience. Transplantation 2002; 73: 553-555.
59. Troxell ML, Koslin DB, Norman D, Rayhill S, Mittalhenkle A. Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies. Transplantation 2010; 90: 75-84.
60. White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet 2009; 373: 1808-1817.
61. Goel G, Perkins BA. Can improved glycemic control slow renal function decline at all stages of diabetic nephropathy? Semin Nephrol 2012; 32: 423-431.
62. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. New Eng J Med 1998; 339: 69-75.
63. Mauer M, Fioretto P. Pancreas transplantation and reversal of diabetic nephropathy lesions. Med Clin North Am 2013; 97: 109-114.
64. Boggi U, Vistoli F, Amorese G, Giannarelli R, Coppelli A, Mariotti R et al. Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients. Rev Diab Stud 2011; 8: 259-267.
65. Bohman SO, Tyden G, Wilczek H, Lundgren G, Jaremko G, Gunnarsson R et al. Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 1985; 34: 306-308.
66. Kleinclauss F, Fauda M, Sutherland DE, Kleinclauss C, Gruessner RW, Matas AJ et al. Pancreas after living donor kidney transplants in diabetic patients: impact on long-term kidney graft function. Clin Transplant 2009; 23: 437-446.
67. Browne S, Gill J, Dong J, Rose C, Johnston O, Zhang P et al. The impact of pancreas transplantation on kidney allograft survival. Am J Transplant 2011; 11: 1951-1958.
68. Navarro X, Kennedy WR, Loewenson RB, Sutherland DE. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990; 39: 802-806.
69. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. New Eng J Med 1990; 322: 1031-1037.
70. Allen RD, Al-Harbi IS, Morris JG, Clouston PD, O'Connell PJ, Chapman JR et al. Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 1997; 63: 830-838.
71. Martinenghi S, Comi G, Galardi G, Di Carlo V, Pozza G, Secchi A. Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas. Diabetologia 1997; 40: 1110-1112.
72. Shtein RM, Callaghan BC. Corneal confocal microscopy as a measure of diabetic neuropathy. Diabetes 2013; 62: 25-26.
73. Tavakoli M, Mitu-Pretorian M, Petropoulos IN, Fadavi H, Asghar O, Alam U et al. Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes 2013; 62: 254-260.
74. Giannarelli R, Coppelli A, Sartini MS, Del Chiaro M, Vistoli F, Rizzo G et al. Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients. Diabetologia 2006; 49: 2977-2982.
75. Koznarova R, Saudek F, Sosna T, Adamec M, Jedinakova T, Boucek P et al. Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000; 9: 903-908.
76. Chow V, Pai R, Chapman J, O'connell P, Allen R, Mitchell P et al. Diabetic retinopathy after combined kidney-pancreas transplantation. Clin Transplant 1999; 13: 356-362.
77. Sosna T, Saudek F, Dominek Z. Effect of successful combined renal and pancreatic transplantation on diabetic retinopathy. Acta Univ Palacki Olomuc Fac Med 1998; 141: 75-77.
78. Scheider A, Meyer-Schwickerath E, Nusser J, Land W, Landgraf R. Diabetic retinopathy and pancreas transplantation: a 3-year follow-up. Diabetologia 1991; 34: S95-S99.
79. Ramsay RC, Goetz FC, Sutherland DE, Mauer SM, Robison LL, Cantrill HL et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. New Eng J Med 1988; 318: 208-214.
80. La Rocca E, Fiorina P, di Carlo V, Astorri E, Rossetti C, Lucignani G et al. Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 2001; 60: 1964-1971.
81. Luan FL, Miles CD, Cibrik DM, Ojo AO. Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation 2007; 84: 541-544.
82. Fiorina P, La Rocca E, Astorri E, Lucignani G, Rossetti C, Fazio F et al. Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients. Diabetes Care 2000; 23: 1804-1810.
83. Stadler M, Theuer E, Anderwald C, Hanusch-Enserer U, Auinger M, Bieglmayer C et al. Persistent arterial stiffness and endothelial dysfunction following successful pancreas-kidney transplantation in Type 1 diabetes. Diabetic Med 2009; 26: 1010-1018.
84. Fiorina P, Folli F, Maffi P, Placidi C, Venturini M, Finzi G et al. Islet transplantation improves vascular diabetic complications in patients with diabetes who underwent kidney transplantation: a comparison between kidney-pancreas and kidney-alone transplantation. Transplantation 2003; 75: 1296-1301.
85. Jukema JW, Smets YF, van der Pijl JW, Zwinderman AH, Vliegen HW, Ringers J et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002; 25: 906-911.
86. Mumford L. 2013 Solid pancreas transplantation (Pancreas forum) NHS Blood and Transplant. Available at http://www.odt.nhs.uk/uk-transplant-registry/presentations. Last accessed 3 July 2013.